Biotest Pharmaceuticals Corporation (BPC), Boca Raton, USA, a 100% subsidiary of Biotest AG, Germany, a manufacturer of plasma proteins and biological products, announcea the addition of its newest plasma collection centre located at Vermillion, South Dakota, USA. The state-of-the-art facil ... more
Immunic AG (Immunic), a biotech company in Planegg-Martinsried near Munich, Germany, announced that it acquired 4SC AG’s (4SC) immunology portfolio, which includes two drug development programs and associated intellectual property and know-how. Immunic will continue all research and develop ... more
A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV that circulate worldwide. Researchers from the University of Zurich and University Hospital Zu ... more
Contract contains antibody cell line development and antibody production
WILEX AG, announced that its subsidiary Heidelberg Pharma, has signed an agreement with Celonic AG, Basel, Switzerland, a specialist in the development and manufacturing of biologics (CDMO). This agreement includes cell line development and the production of non-GMP and GMP (Good Manufactur ... more
Glioblastomas are incurable malignant brain tumors. Usually the patients affected survive for only a few months. In addition, every tumor is quite different, which makes treatment very difficult. Researchers at the University of Bonn have now developed a completely new method as the basis f ... more
Evotec AG announced that Evotec and Bayer have entered into a five-year, multi-target research partnership. The goal is the development of multiple clinical candidates for the treatment of kidney diseases such as chronic kidney disease in diabetes patients. Both companies will contribute no ... more
Using light to target and kill cancer cells alternatively without surgery
A new study, affiliated with UNIST has presented a natural, alternative, and holistic cancer treatment that uses light to selectively wipe out cancerous cells without harming surrounding tissue. With further research, this novel method might eventually be used to treat tumors in humans.
Thi ... more
The U.S. Food and Drug Administration approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skip ... more
The U.S. Food and Drug Administration (FDA) has approved Bayer AG’s new low dose levonorgestrel-releasing intrauterine system (LNG-IUS) which will be marketed in the US under the brand name Kyleena™. Kyleena releases the lowest daily dose of the hormone levonorgestrel in an intrauterine sys ... more
The Dutch biopharmaceutical company Lanthio Pharma B.V., a wholly owned subsidiary of MorphoSys AG, announced the appointment of Axel Mescheder, M.D. as Chief Medical Officer (CMO).
Dr. Heinz Schwer, Chief Executive Officer of Lanthio Pharma, commented: "We are very pleased to welcome Axel ... more